A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
Clinical trial NCT05794906 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05794906
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2027-07-30
- Enrollment
- 985
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.